[Progesterone therapy of endometrial cancer].
Mayo Medical School, Rochester, Minnesota.
M J
MJ
Webb
D016889:Endometrial Neoplasms / Q000401:mortality / Q000628:therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000401:mortality / Q000628:therapy; D009376:Neoplasms, Hormone-Dependent / Q000401:mortality / Q000628:therapy*; D011374:Progesterone / Q000627:therapeutic use*; D045167:Progesterone Congeners / Q000627:therapeutic use*; D011980:Receptors, Progesterone / Q000187:drug effects*; D015996:Survival Rate
D045167:Progesterone Congeners; D011980:Receptors, Progesterone; D011374:Progesterone
Progesterontherapie des Endometriumkarzinoms.